Delenex raises CHF13.5 million

Delenex Therapeutics AG (Zurich, Switzerland) raised CHF13.5 million ($14 million) in a series A round led by SV Life Sciences; HBM BioCapital; HBM BioVentures; BioMedInvest; and VI Partners. Delenex ...